Adam Maeder

Stock Analyst at Piper Sandler

(1.45)
# 1713
Out of 5,370 analysts
139
Total ratings
50.00%
Success rate
8.28%
Average return
21 Stocks
Name Action PT Current % Upside Ratings Updated
EW Edwards Lifesciences
Maintains: Overweight
80 83
74.71 11.1% 15 May 13, 2025
NSPR InspireMD
Maintains: Overweight
5 4
2.47 61.94% 4 May 12, 2025
TCMD Tactile Systems Tech
Downgrades: Neutral
25 14
9.87 41.84% 3 May 6, 2025
RMD ResMed
Maintains: Neutral
260 248
251.37 -1.34% 3 Apr 24, 2025
ISRG Intuitive Surgical
Maintains: Overweight
670 575
518.65 10.86% 19 Apr 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
133 145
133.99 8.22% 3 Apr 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
18
14.06 28.02% 1 Apr 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
11 9
8.18 3.91% 7 Mar 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
260 233
129.39 80.08% 14 Feb 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
6 6
n/a n/a 16 Feb 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
52 80
n/a n/a 7 Jan 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
20 21
11.87 76.92% 2 May 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
18 20
n/a n/a 6 May 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
290 360
n/a n/a 10 Apr 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
7 8
3.65 119.18% 1 Mar 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
15 20
7.74 158.4% 8 Mar 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
75 71
n/a n/a 8 Jan 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
6 5
2.16 131.48% 2 Mar 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
10 18
2.37 659.49% 2 Jan 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
104 99
45.45 117.82% 3 May 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
9 11
n/a n/a 5 Jun 14, 2021